are caused by α-amanitin, one of the most lethal mushroom toxins known to science. In Germany, the death cap mushroom contains the highest concentration of α-aminitin. Half of a mushroom is enough to kill a human.
α-amanitin effectively inhibits the activity of RNA Polymerase II, resulting in a reduced synthesis of messenger RNA and therefore protein production.
The death cap mushroom is often mistaken for edible varieties, making it extremely dangerous.
Up to now, there is no highly specific antidote that targets the α-amanitin.
Nanobodies, like bigger antibodies, bind specifically to the antigen, providing a highly selective tool for therapeutics.
Our nanobody is designed using cutting edge in silico methods, allowing to design therapeutic instruments with ease.
With the design of state-of-the-art lipid nanoparticles, we aim to deliver our highly specific nanobodies to the liver, the main target organ of α-amanitin. By packaging the designed nanobodies, it starts to be a promising therapeutic option.